#JITC Research: MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment https://t.co/82dyxGyAvK https://t.co/9uZtViRi2O
8,103 followers
814 followers
RT @jitcancer: New Journal for ImmunoTherapy of Cancer (#JITC) Research: MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhan…
8,103 followers
New Journal for ImmunoTherapy of Cancer (#JITC) Research: MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment https://t.co/82dyxGyAvK https://t.co/K3T3e6pK0J
8,103 followers
New #JITC Research: MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment https://t.co/82dyxGyAvK https://t.co/w8Xw7WFVMH